BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1861541)

  • 1. Simplified quantitative estimation in vitro of lymphocyte radiosensitivity applied to patients with chronic lymphocytic leukaemia.
    Thomson AE; Wetherley-Mein G; O'Connor TW; Still B; Peel WE; Slater NG; Bates T
    Leuk Res; 1991; 15(7):577-89. PubMed ID: 1861541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous X-ray survival characteristics of lymphocytes in prolymphocytic leukaemia: mathematical analysis distinguishing delayed cell death and true radioresistance.
    Thomson AE; O'Connor TW; Peel WE; Slater NG
    Eur J Haematol; 1994 Oct; 53(4):223-31. PubMed ID: 7957807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intrinsic radiosensitivity of lymphocytes in chronic lymphocytic leukaemia, quantitatively determined independently of cell death rate factors.
    Thomson AE; Vaughan-Smith S; Peel WE; Wetherley-Mein G
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Dec; 48(6):943-61. PubMed ID: 3877700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between in vitro and in vivo radiosensitivity of lymphocytes in chronic lymphocytic leukemia.
    Schrek R; Best WR; Stefani S
    Acta Haematol; 1988; 80(3):129-33. PubMed ID: 3143211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical model resolving normal human blood lymphocyte population x-ray survival curves into six components: radiosensitivity, death rate and size of two responding subpopulations.
    Thomson AE; Vaughan-Smith S; Peel WE
    Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Jan; 41(1):15-32. PubMed ID: 6977506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro radiosensitivity of lymphocytes from chronic lymphocytic leukaemia using the differential staining cytotoxicity (DiSC) assay. II--Results on 40 patients.
    Hinkley HJ; Bosanquet AG
    Int J Radiat Biol; 1992 Jan; 61(1):111-21. PubMed ID: 1370317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of B-CLL cells apoptotic responses to irradiation.
    Comby E; Andre I; Troussard X; Lebrun E; Sola B; Ballet JJ; Leporrier M
    Leuk Lymphoma; 1999 Jun; 34(1-2):159-66. PubMed ID: 10350344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of splenic irradiation on lymphocyte subpopulations in chronic B-lymphocytic leukemia.
    Terstappen LW; de Grooth BG; van Berkel W; ten Napel CH; van Reijn M; Greve J
    Eur J Haematol; 1988 Nov; 41(5):496-505. PubMed ID: 3264792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idelalisib may have the potential to increase radiotherapy side effects.
    Gryc T; Putz F; Goerig N; Ziegler S; Fietkau R; Distel LV; Schuster B
    Radiat Oncol; 2017 Jun; 12(1):109. PubMed ID: 28659152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro radiosensitivity of lymphocytes from chronic lymphocytic leukaemia using the differential staining cytotoxicity (DiSC) assay. I--Investigation of the method.
    Hinkley HJ; Bosanquet AG
    Int J Radiat Biol; 1992 Jan; 61(1):103-10. PubMed ID: 1370316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low-dose irradiation on unstimulated and PHA-stimulated human lymphocyte subsets.
    Stewart CC; Stevenson AP; Habbersett RC
    Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Jan; 53(1):77-87. PubMed ID: 3257480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.
    Vandenbulcke K; De Vos F; Offner F; Philippé J; Apostolidis C; Molinet R; Nikula TK; Bacher K; de Gelder V; Vral A; Lahorte C; Thierens H; Dierckx RA; Slegers G
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1357-64. PubMed ID: 12845484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of leukemic cell proliferation by factor(s) released from irradiated lymphocytes of B-chronic lymphocytic leukemia patients.
    Bessler H; Notti I; Cohen AM; Klein B; Djaldetti M
    Am J Hematol; 1994 Jun; 46(2):65-71. PubMed ID: 8172197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model for intractable chronic lymphocytic leukemia.
    Schrek R
    Med Hypotheses; 1990 Nov; 33(3):175-6. PubMed ID: 1963468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topological DNA target size model.
    Suciu D
    Radiat Environ Biophys; 1990; 29(3):203-11. PubMed ID: 2396009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
    Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
    Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells.
    Blaise R; Alapetite C; Masdehors P; Merle-Beral H; Roulin C; Delic J; Sabatier L
    Int J Radiat Biol; 2002 Aug; 78(8):671-9. PubMed ID: 12194750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.